• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 MYC 抑制后复发的淋巴瘤继续表现出癌基因成瘾。

Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction.

机构信息

Division of Oncology, Department of Medicine and Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.

出版信息

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17432-7. doi: 10.1073/pnas.1107303108. Epub 2011 Oct 3.

DOI:10.1073/pnas.1107303108
PMID:21969595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3198348/
Abstract

The suppression of oncogenic levels of MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or apoptosis, a phenomenon known as oncogene addiction. However, after prolonged inactivation of MYC in a conditional transgenic mouse model of Eμ-tTA/tetO-MYC T-cell acute lymphoblastic leukemia, some of the tumors recur, recapitulating what is frequently observed in human tumors in response to targeted therapies. Here we report that these recurring lymphomas express either transgenic or endogenous Myc, albeit in many cases at levels below those in the original tumor, suggesting that tumors continue to be addicted to MYC. Many of the recurring lymphomas (76%) harbored mutations in the tetracycline transactivator, resulting in expression of the MYC transgene even in the presence of doxycycline. Some of the remaining recurring tumors expressed high levels of endogenous Myc, which was associated with a genomic rearrangement of the endogenous Myc locus or activation of Notch1. By gene expression profiling, we confirmed that the primary and recurring tumors have highly similar transcriptomes. Importantly, shRNA-mediated suppression of the high levels of MYC in recurring tumors elicited both suppression of proliferation and increased apoptosis, confirming that these tumors remain oncogene addicted. These results suggest that tumors induced by MYC remain addicted to overexpression of this oncogene.

摘要

抑制致癌水平的 MYC 足以诱导持续的肿瘤消退,与增殖停滞、分化、细胞衰老和/或细胞凋亡相关,这种现象被称为癌基因成瘾。然而,在条件性转基因小鼠模型中,Eμ-tTA/tetO-MYC T 细胞急性淋巴细胞白血病中 MYC 的长期失活后,一些肿瘤会复发,这与靶向治疗后经常在人类肿瘤中观察到的情况类似。在这里,我们报告说,这些复发性淋巴瘤表达转基因或内源性 Myc,尽管在许多情况下,其水平低于原始肿瘤中的水平,这表明肿瘤仍然对 MYC 有依赖性。许多复发性淋巴瘤(76%)携带四环素转录激活剂的突变,导致即使存在强力霉素,MYC 转基因也会表达。一些剩余的复发性肿瘤表达高水平的内源性 Myc,这与内源性 Myc 基因座的基因组重排或 Notch1 的激活有关。通过基因表达谱分析,我们证实了原发性和复发性肿瘤具有高度相似的转录组。重要的是,shRNA 介导的对复发性肿瘤中高水平 MYC 的抑制既抑制了增殖,又增加了细胞凋亡,证实这些肿瘤仍然对癌基因有依赖性。这些结果表明,由 MYC 诱导的肿瘤仍然依赖于这种致癌基因的过度表达。

相似文献

1
Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction.在 MYC 抑制后复发的淋巴瘤继续表现出癌基因成瘾。
Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17432-7. doi: 10.1073/pnas.1107303108. Epub 2011 Oct 3.
2
Addiction to multiple oncogenes can be exploited to prevent the emergence of therapeutic resistance.对多个癌基因的成瘾可以被利用来防止治疗抵抗的出现。
Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):E3316-24. doi: 10.1073/pnas.1406123111. Epub 2014 Jul 28.
3
Expression of lymphomagenic oncogenes in T-cell lymphomas of HPV 16 transgenic mice.人乳头瘤病毒16型转基因小鼠T细胞淋巴瘤中致淋巴瘤癌基因的表达
Cancer Detect Prev. 1998;22(5):405-15. doi: 10.1046/j.1525-1500.1998.00059.x.
4
Generation of a Tetracycline Regulated Mouse Model of MYC-Induced T-Cell Acute Lymphoblastic Leukemia.生成四环素调控的 MYC 诱导 T 细胞急性淋巴细胞白血病小鼠模型。
Methods Mol Biol. 2021;2318:297-312. doi: 10.1007/978-1-0716-1476-1_16.
5
p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia.在急性白血病小鼠模型中,p19ARF是细胞衰老以及与MYC失活相关的先天免疫反应的关键介质。
Oncotarget. 2015 Feb 28;6(6):3563-77. doi: 10.18632/oncotarget.2969.
6
Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.MYC和K-Ras癌基因的联合失活可逆转肺腺癌和淋巴瘤的肿瘤发生。
PLoS One. 2008 May 7;3(5):e2125. doi: 10.1371/journal.pone.0002125.
7
Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.在来自TCR转基因小鼠的胸腺淋巴瘤中,Ras、Raf和L-myc的过表达而非Bcl-2家族蛋白的过表达与对TCR介导的细胞凋亡的抗性及肿瘤发生相关。
Leuk Res. 2000 Jan;24(1):33-8. doi: 10.1016/s0145-2126(99)00157-5.
8
High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia.T细胞急性淋巴细胞白血病中诱导Myc的Notch1突变的高选择压力。
Blood. 2016 Nov 3;128(18):2229-2240. doi: 10.1182/blood-2016-01-692855. Epub 2016 Sep 26.
9
Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.与CD2基因显性控制区相关的c-myc的条件性表达及致癌性
Int J Cancer. 1993 Apr 1;53(6):1023-30. doi: 10.1002/ijc.2910530628.
10
The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.MMTV/c-myc转基因和p53无效等位基因协同作用,在转基因小鼠中诱导T细胞淋巴瘤,但不诱导乳腺癌。
Oncogene. 1995 Jul 6;11(1):181-90.

引用本文的文献

1
Modeling tumor relapse using proliferation tracing and ablation transgenic mouse.使用增殖追踪和消融转基因小鼠对肿瘤复发进行建模。
NPJ Breast Cancer. 2025 Jul 17;11(1):73. doi: 10.1038/s41523-025-00792-1.
2
Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma.利用 MYC 诱导的淋巴瘤基因工程小鼠模型获得的经验教训。
Cells. 2022 Dec 22;12(1):37. doi: 10.3390/cells12010037.
3
Tilting MYC toward cancer cell death.使 MYC 向癌细胞死亡倾斜。
Trends Cancer. 2021 Nov;7(11):982-994. doi: 10.1016/j.trecan.2021.08.002. Epub 2021 Sep 2.
4
A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation.治疗性致癌基因失活后肿瘤消退和复发的数学模型。
Sci Rep. 2021 Jan 14;11(1):1341. doi: 10.1038/s41598-020-78947-2.
5
Transcriptional Activation of MYC-Induced Genes by GCN5 Promotes B-cell Lymphomagenesis.GCN5 转录激活 MYC 诱导基因促进 B 细胞淋巴瘤的发生。
Cancer Res. 2020 Dec 15;80(24):5543-5553. doi: 10.1158/0008-5472.CAN-20-2379. Epub 2020 Nov 9.
6
MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies.MYC 作为自然杀伤细胞介导的淋巴恶性肿瘤免疫监视的开关发挥作用。
Nat Commun. 2020 Jun 5;11(1):2860. doi: 10.1038/s41467-020-16447-7.
7
PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas.PLK1 在侵袭性 B 细胞淋巴瘤中稳定了一个依赖 MYC 的激酶网络。
J Clin Invest. 2018 Dec 3;128(12):5517-5530. doi: 10.1172/JCI122533. Epub 2018 Nov 5.
8
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers.Hgf/Met 激活介导了鼠源间变性甲状腺癌对 BRAF 抑制的耐药性。
J Clin Invest. 2018 Aug 31;128(9):4086-4097. doi: 10.1172/JCI120966. Epub 2018 Aug 20.
9
DNA-binding of the Tet-transactivator curtails antigen-induced lymphocyte activation in mice.Tet反式激活因子与DNA的结合可抑制小鼠体内抗原诱导的淋巴细胞活化。
Nat Commun. 2017 Oct 18;8(1):1028. doi: 10.1038/s41467-017-01022-4.
10
The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas.线粒体翻译机制作为Myc驱动淋巴瘤的治疗靶点。
Oncotarget. 2016 Nov 8;7(45):72415-72430. doi: 10.18632/oncotarget.11719.

本文引用的文献

1
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.黑色素瘤通过 RTK 或 N-RAS 上调获得对 B-RAF(V600E)抑制的耐药性。
Nature. 2010 Dec 16;468(7326):973-7. doi: 10.1038/nature09626. Epub 2010 Nov 24.
2
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.COT 通过激活 MAP 激酶通路驱动 RAF 抑制耐药。
Nature. 2010 Dec 16;468(7326):968-72. doi: 10.1038/nature09627. Epub 2010 Nov 24.
3
CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.CD4(+) T 细胞有助于重塑微环境,这是癌基因失活后持续肿瘤消退所必需的。
Cancer Cell. 2010 Nov 16;18(5):485-98. doi: 10.1016/j.ccr.2010.10.002. Epub 2010 Oct 28.
4
The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance.Myc 和 Miz1 之间的相互作用对于拮抗淋巴瘤形成和维持过程中 TGFβ 依赖性自分泌信号是必需的。
Genes Dev. 2010 Jun 15;24(12):1281-94. doi: 10.1101/gad.585710.
5
Targeting epidermal growth factor receptor: central signaling kinase in lung cancer.靶向表皮生长因子受体:肺癌中的中央信号激酶。
Biochem Pharmacol. 2010 Sep 1;80(5):613-23. doi: 10.1016/j.bcp.2010.05.014. Epub 2010 May 24.
6
Oncogenic K-ras "addiction" and synthetic lethality.致癌性K-ras“成瘾”与合成致死性
Cell Cycle. 2009 Sep 1;8(17):2676-7. doi: 10.4161/cc.8.17.9336. Epub 2009 Sep 23.
7
Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A.前T细胞受体信号通过拮抗E2A使Notch1转录失活。
Genes Dev. 2009 Jul 15;23(14):1665-76. doi: 10.1101/gad.1793709.
8
Myc's broad reach.Myc的广泛影响范围。
Genes Dev. 2008 Oct 15;22(20):2755-66. doi: 10.1101/gad.1712408.
9
Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.MYC和K-Ras癌基因的联合失活可逆转肺腺癌和淋巴瘤的肿瘤发生。
PLoS One. 2008 May 7;3(5):e2125. doi: 10.1371/journal.pone.0002125.
10
Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?癌基因成瘾与癌基因遗忘:或许不仅仅是一种不良习惯?
Cancer Res. 2008 May 1;68(9):3081-6; discussion 3086. doi: 10.1158/0008-5472.CAN-07-5832.